Psychedelics and Cannabis: An All-in-One Unique Profit Opportunity to Act on Now!

[Image]( Psychedelics and Cannabis An All-in-One Unique Profit Opportunity to Act on Now! International mental health medical company adds psilocybin to its US cannabis patent mix. With a combined market soaring toward $60 billion, this could be a monster! Greetings Fellow Investor, Widespread legalization, FDA approvals, breakthrough medical discoveries...and this time it’s not just cannabis...it’s now also psilocybin. The “magic mushroom,” previously known for its psychedelic properties, has been discovered to hold highly efficacious therapeutic potential for treatment of mental disorders and brain injuries. [Psychedelics Is a Sector Packed With Winners… and It’s Only the Beginning]( The FDA has fast-tracked psilocybin after clinical trials prove its efficacy treating PTSD, depression and opioid addiction. I have been watching closely as investors have responded to this emerging market trend…and the results have been breathtaking. I believe I have discovered a company at the right entry point for growth-oriented investors. The potential here could be stunning. To learn more about this opportunity, please read my urgent new report on this company that stands to become one of the market’s most important suppliers of cannabinoid compounds and psilocybin to global pharmaceutical markets. [Psychedelics and Cannabis Markets Combined Undergoing a Paradigm Shift]( I’ve followed these developments ever since the legalization of medical marijuana gained traction in the US. It’s already abundantly clear that the cannabis industry was set to go to industrial scale. Now, psilocybin has been added to the mix and the combination of both in one company promises to be disruptive. You could see massive growth in your wealth if you make the right choices now. From the outset, I anticipated I’d find one forward-looking company emerge with a totally new and transformative business model for producing cannabinoids, and now psychedelic compounds, for use in industrial quantities. I believe independent producers that dominated the last decade of growth simply will not be able to meet the stringent and massive supply requirements about to be created by this booming market. I saw this as inevitable, so I began monitoring a number of producing international companies showing potential to grow seamlessly into this burgeoning arena. One has clearly risen to the top — providing a clear ground floor opportunity — and it trades right here in the US. I’ve just completed a detailed report into its business model and its exceptional investment potential...and I want you to have it with my compliments. [Now Could Be the Ideal Time for You to Get in Front of This]( Everything about this company has been geared to high-quality, low-cost production of these organic compounds, all in scalable quantities and consistent quality that major buyers can depend upon year-after-year. This will be key to the mainstream adoption of cannabinoids and psilocybin for conventional medicine. Big pharma enters this space with no currently known reliable, scalable combined supply channels for cannabinoids, psilocybin, or other compounds now gathering clinical traction. This company has built a vertically integrated, end-to-end supply chain that extends from plant propagation to high purity extraction. Everything necessary is covered within its own operations — even shipping from its cultivation farms to partnered extraction labs. It also manages one of the world’s leading horticultural labs where proprietary plants are developed bearing the highest concentrations of recoverable compounds. Provisional patents related to PTSD have already been granted on their formulation and derived associated intellectual property. Few opportunities I’ve seen in my multi-decade career show such obvious growth potential...and this one is just getting started. It’s a ground floor opportunity with incredible upside potential. [Click Here For Your FREE Report to Discover My Top Pick for 2021]( One Last Parting Thought: In my report you’ll find a revenue chart that clearly portrays the stunning pace of growth anticipated for this company. Management forecasts 2021 revenue to grow nearly nine-fold over the next two years, propelled by a blistering hot market just now gaining traction. This is unlikely to remain an entry level opportunity for much longer. I urge you to read my [free report]( without delay. Yours for Prosperity, MF Williams, Contributor For Investor News Service MF Williams came to FNN with an already impressive career analyzing small and microcap companies. He became involved in banking and finance working for BNP Paribas North America in New York City in early 2000. He soon found his true passion in small and microcap sector stocks, with their dramatic potential for upside growth. With over 19 years of experience analyzing and researching emerging small cap public companies, his insight and skill set are unmatched. _________________________ SPONSORED ARTICLE: Investing in any securities is highly speculative. Please be sure to always do your own due diligence before making any investment decisions. Read our full disclaimer [here]( © 202 PTE.la PTE, LLC (publisher of PTE.la) is NOT registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for PTE, LLC may have long or short positions in securities that may be discussed on this website or newsletter. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are simulated figures from virtual simulated portfolios. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. PTE.la’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as are commendation by PTE.la or an offer or solicitation to buy or sell any security. Neither the owner of PTE.la nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with alicensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit . PTE.la makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. PTE.la is owned and operated by PTE LLC. PTE LLC has not been compensated for this specific email, we do have advertisements in this email that we get paid if you click one of the ads (we have not investigated any of the advertisements). Any compensation received by PTE LLC constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. A third party of PTE LLC may have shares and may liquidate, which may negatively affect the stock price. PTE LLC affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market. Some of the content in this release contains forward - looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward - looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company’s filings with the Securities and Exchange Commission. However, acompany’s past performance does not guarantee future results. Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. PTE.la makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. PTE Team 9 Downing street Newark NJ 07105 USA [Unsubscribe]( | [Change Subscriber Options](